Replies to post #95060 on Biotech Values

[DewDiligence]

DNDN:

…I also believe they'll partner Provenge for licensing, distribution and sales outside the U.S.

There you go again, talking about your beliefs irrespective of any empirical evidence to back them up. DNDN’s executives made it clear on last week’s CC that they intend to pursue ex-US commercial opportunities for Provenge without a partner.